JPRN-UMIN000054129尚未招募Unknown
Preliminary Clinical Trial on Leucine Requirement in Japanese Adult Men Using the Indicator Amino Acid Oxidation (IAAO) Method - Preliminary Clinical Trial on Leucine Requirement in Japanese Adult Men Using the Indicator Amino Acid Oxidation (IAAO) Method
CPCC Company Limited0 个研究点目标入组 2 人开始时间: 2024年4月12日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 2
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 60years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1. Subjects who are aware of a weight change of more than 5 kg in the month prior to obtaining consent. 2. Subjects with excessive alcohol intake. 3. Subjects suffering from diseases that affect protein and amino acid metabolism, such as diabetes, cancer, liver disease, kidney disease, HIV, etc. 4. Subjects with previous and/or current medical history of serious diseases in heart, liver, kidney and/or digestive organs. 5. Subjects with allergies to medications and/or food. 6. Subjects who donated blood or component (200 mL) within the last 1 months. 7. Subjects who donated blood (400 mL) within the last 3 months. 8. Subjects who being collected in total of blood (1200 mL) within the last 12 months and in this study. 9. Subjects deemed unsuitable for participation in the trial by the principal investigator or sub-investigator.
研究者
相似试验
已完成
2 期
Clinical trial to investigate the effect of intake of sudachi peel on risk factor of metabolic syndromeMetabolic syndromeJPRN-UMIN000002682Tokushima University Hospital40
招募中
不适用
Study on navauppu mezhugu in dysmenorrhoeaCTRI/2017/06/008938Ayothidas pandithar hospital10
尚未招募
2 期
Vel Tooth powder against dental biofilm and Gingival bleeding among ChildreCTRI/2023/09/058077ational Institute of Siddha
已完成
1 期
Phase I/II clinical trial of biologic therapy with intratumoral TG1042 (Adenovirus-Interferon-gamma) in patients with Advanced Cutaneous T-Cell Lymphomas (CTCL) - Mycosis Fungoides and other CTCL - and multilesional Cutaneous B-Cell Lymphomas (CBCL)C84C84.0C85.1Mature T/NK-cell lymphomasMycosis fungoidesB-cell lymphoma, unspecifiedDRKS00000219Transgene39
进行中（未招募）
1 期
Phase I clinical trial on the use of fresh, allogeneic, second-generation CD19-CAR T cells for treatment of children and young adult with relapsed/refractory B-cell Acute Lymphoblastic LeukemiaRelapsed/refractory B-cell Acute Lymphoblastic LeukemiaCTIS2023-508420-36-00Ospedale Pediatrico Bambino Gesu'24